Moreover, in a murine orthotopic liver cancer model, the combination of anti-GM-CSF and anti-PD-L1 antibodies inhibited the differentiation of PD-L1(+) TAMs, reduced their contact with CD8(+) T cells, alleviated T cell exhaustion, and potentiated antitumor immunity. This evidence concerns the gene CD274 and liver cancer.